- Home
- Publications
- Publication Search
- Publication Details
Title
Options to Overcome Clopidogrel Response Variability
Authors
Keywords
-
Journal
CIRCULATION JOURNAL
Volume 76, Issue 2, Pages 287-292
Publisher
Japanese Circulation Society
Online
2012-01-12
DOI
10.1253/circj.cj-11-1494
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Outcomes of High On-Treatment Platelet Reactivity in Koreans Receiving Elective Percutaneous Coronary Intervention (from Results of the CROSS VERIFY Study)
- (2011) Kyung Woo Park et al. AMERICAN JOURNAL OF CARDIOLOGY
- Efficacy and Safety of Intensive Antiplatelet Therapy With Prasugrel from TRITON-TIMI 38 in a Core Clinical Cohort Defined by Worldwide Regulatory Agencies
- (2011) Stephen D. Wiviott et al. AMERICAN JOURNAL OF CARDIOLOGY
- Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention
- (2011) Matthew J. Price JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy of Predicting Thrombotic Events with Combination of Dual Point-of-Care Testing (POCT) after Drug-Eluting Stent Implantation for Coronary Heart Disease: Results from the CILON-T Randomized Trial POCT Substudy
- (2011) Seung-Pyo Lee et al. Journal of Atherosclerosis and Thrombosis
- Multicenter Randomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complications After Drug-Eluting Stent Implantation for Coronary Heart Disease
- (2011) Jung-Won Suh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prospective Evaluation of On-Clopidogrel Platelet Reactivity Over Time in Patients Treated With Percutaneous Coronary Intervention
- (2011) Gianluca Campo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
- (2011) Glenn N. Levine et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy
- (2011) Dominick J. Angiolillo et al. THROMBOSIS AND HAEMOSTASIS
- Efficacy of Cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials
- (2011) Umesh Tamhane et al. EuroIntervention
- Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry)
- (2010) Seung-Whan Lee et al. AMERICAN HEART JOURNAL
- Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies
- (2010) Paul A. Gurbel et al. CIRCULATION
- Impact of Cytochrome P450 2C19*2 Polymorphism on Intra-Stent Thrombus After Drug-Eluting Stent Implantation in Japanese Patients Receiving Clopidogrel
- (2010) Takahiro Sawada et al. CIRCULATION JOURNAL
- Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy
- (2010) Koichiro Yamamoto et al. Journal of Cardiology
- Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis
- (2010) Jessica L Mega et al. LANCET
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
- (2010) Lars Wallentin et al. LANCET
- The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response
- (2010) Ankie Harmsze et al. THROMBOSIS AND HAEMOSTASIS
- Predictors of Heightened Platelet Reactivity Despite Dual-Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention
- (2009) Matthew J. Price et al. AMERICAN JOURNAL OF CARDIOLOGY
- Comparison of Triple Antiplatelet Therapy and Dual Antiplatelet Therapy in Patients at High Risk of Restenosis After Drug–Eluting Stent Implantation (from the DECLARE-DIABETES and -LONG Trials)
- (2009) Seung-Whan Lee et al. AMERICAN JOURNAL OF CARDIOLOGY
- Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- (2009) Kang-Yin Chen et al. CIRCULATION
- Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease
- (2009) Paul A. Gurbel et al. CIRCULATION
- Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel
- (2009) Jessica L. Mega et al. CIRCULATION
- Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite
- (2009) M. Kazui et al. DRUG METABOLISM AND DISPOSITION
- Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
- (2009) P. Michael Ho JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized Comparison of Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With High Post-Treatment Platelet Reactivity
- (2009) Young-Hoon Jeong et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
- (2009) Gilles Montalescot et al. LANCET
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
- (2008) Stephen D. Wiviott et al. CIRCULATION
- A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study
- (2008) D. J. Angiolillo et al. EUROPEAN HEART JOURNAL
- Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation
- (2008) Matthew J. Price et al. EUROPEAN HEART JOURNAL
- Calcium-Channel Blockers Reduce the Antiplatelet Effect of Clopidogrel
- (2008) Jolanta M. Siller-Matula et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
- (2008) Tabassome Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now